News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ColonCancer’ clear

  • Researchers found patients who engaged in moderate physical activity were 53 percent more likely to be free of colorectal cancer than those who were less physically active.

Tags: ColonCancer

  •  

    Patients with colon cancer who used multivitamins did not reduce the risk of cancer recurrence, though there may be some benefit to patients 60 and younger.

Tags: ColonCancer

  • The reduced risk of colorectal cancer associated with taking aspirin or NSAIDs may be confined to individuals already at risk because of elevations in a particular inflammatory factor in the blood, researchers at Dana-Farber Cancer Institute and Massachusetts General Hospital report.

Tags: ColonCancer, Prevention

  • A protein biomarker may predict better chances of survival for obese patients with colorectal cancer, but it provided no prognostic value for non-obese patients, Dana-Farber researchers report.

Tags: ColonCancer

  • Dana-Farber researchers have discovered how some cancer cells can evade the effect of cetuximab. This insight may explain why some cancers that initially respond to cetuximab become resistant to it, or how to overcome such resistance.

Tags: ColonCancer, EGFR, TargetedTherapy

  • Dana-Farber and the Broad Institute researchers have found high levels of the bacterium Fusobacterium in colorectal cancers, a sign that it might contribute to the disease and potentially lead to further research.

Tags: BasicResearch, ColonCancer, Genomics

  • Newly discovered gene mutations in certain non-small cell and colorectal cancers share similarities with other genetic abnormalities that are known to respond to targeted cancer treatments. This suggests that existing therapies, already approved, could be used to treat patients with these tumors.

Tags: ColonCancer, Genomics, KinaseInhibitor, LungCancer, TargetedTherapy

  • Colorectal cancer is the second leading cause of cancer deaths in the United States. Many people have no symptoms in the early stages of the disease. Doctors are reminding people about the importance of being regularly screened to help save lives.

Tags: ColonCancer, Prevention

  • A new study by Dana-Farber researchers shows aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but has no effect on patients who lack the mutation.

Tags: ColonCancer, Genetics

  • Dana-Farber Cancer Institute researchers report that when people with a family history of colorectal cancer develop the disease, their tumors often carry a molecular sign that the cancer could be life-threatening.

Tags: ColonCancer

Showing 11-20 of 24 items